Bio-Path Holdings Inc. (BPTH): Prakiraan wutah bathi kanggo taun ngarep

The development of targeted therapy to block tumor proteins is driving growth for Bio-Path Holdings (BPTH). Shifts in analyst EPS growth estimates reflect current trends, where the 51.20 metric determines the parameter status. High pricing power potential in hematology via DNAbilize is coupled with capital dilution risks stemming from frequent secondary offerings and uncertainty regarding clinical trial timelines.

BPTH: Prakiraan wutah bathi resik saben saham kanggo taun ngarep Bio-Path Holdings Inc. 04.07.2022 - 01.03.2025

Rincian metrik lan analitis perusahaan biopathholdings.com (BPTH)

- rega lan prakiraan konsensus rega:

Bagan rega Bio-Path|BPTH - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Kapitalisasi pasar Bio-Path Holdings|BPTH - Nilai Bisnis

- indikator kapitalisasi buku:

Nilai Buku saben Saham Bio-Path Holdings|BPTH - Nilai Buku Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku biopathholdings.com|BPTH - Gunggung Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Utang marang Ekuitas Bio-Path Holdings|BPTH - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Bio-Path Holdings, Inc.|BPTH - Tanggungan utang total perusahaan|Rasio utang marang kapitalisasi buku Bio-Path Holdings|BPTH - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Bio-Path Holdings|Indikator likuiditas cepet biopathholdings.com

- informasi bathi lan kelipatan valuasi:

BPTH - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Bio-Path Holdings|BPTH - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Bio-Path Holdings|BPTH - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Bio-Path Holdings|BPTH - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Bio-Path Holdings|BPTH - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan biopathholdings.com|BPTH - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Bio-Path Holdings

Analisis kabeh metrik perusahaan:BPTH, Bio-Path

This indicator measures the percentage change in expected earnings per share (EPS) for the following year, aggregating analyst consensus forecasts to assess future profitability. For Bio-Path Holdings (BPTH), which lacks commercial products and relies on equity issuance, the expected EPS growth for next year reflects the market's speculative faith in the success of clinical trials amid the absence of its own cash flow.

Karo sapa Bio-Path Holdings saingan